| |||||||
| |||||||
| 1 | AN ACT concerning criminal law. | ||||||
| 2 | Be it enacted by the People of the State of Illinois, | ||||||
| 3 | represented in the General Assembly: | ||||||
| 4 | Section 5. The Illinois Controlled Substances Act is | ||||||
| 5 | amended by changing Section 216 as follows: | ||||||
| 6 | (720 ILCS 570/216) | ||||||
| 7 | Sec. 216. Ephedrine. | ||||||
| 8 | (a) The following drug products containing ephedrine, its | ||||||
| 9 | salts, optical isomers and salts of optical isomers shall be | ||||||
| 10 | exempt from the application of Sections 312 and 313 of this Act | ||||||
| 11 | if they: (i) may lawfully be sold over-the-counter without a | ||||||
| 12 | prescription under the Federal Food, Drug, and Cosmetic Act; | ||||||
| 13 | (ii) are labeled and marketed in a manner consistent with | ||||||
| 14 | Section 341.76 of Title 21 of the Code of Federal Regulations; | ||||||
| 15 | (iii) are manufactured and distributed for legitimate | ||||||
| 16 | medicinal use in a manner that reduces or eliminates the | ||||||
| 17 | likelihood of abuse; and (iv) are not marketed, advertised, or | ||||||
| 18 | labeled for the indications of stimulation, mental alertness, | ||||||
| 19 | weight loss, muscle enhancement, appetite control, or energy: | ||||||
| 20 | (1) Solid oral dosage forms, including soft gelatin | ||||||
| 21 | caplets, which are formulated pursuant to 21 CFR 341 or | ||||||
| 22 | its successor, and packaged in blister packs of not more | ||||||
| 23 | than 2 tablets per blister. | ||||||
| |||||||
| |||||||
| 1 | (2) Anorectal preparations containing not more than 5% | ||||||
| 2 | ephedrine. | ||||||
| 3 | (b) The marketing, advertising, or labeling of any product | ||||||
| 4 | containing ephedrine, a salt of ephedrine, an optical isomer | ||||||
| 5 | of ephedrine, or a salt of an optical isomer of ephedrine, for | ||||||
| 6 | the indications of stimulation, mental alertness, weight loss, | ||||||
| 7 | appetite control, or energy, is prohibited. In determining | ||||||
| 8 | compliance with this requirement the Department may consider | ||||||
| 9 | the following factors: | ||||||
| 10 | (1) The packaging of the drug product; | ||||||
| 11 | (2) The name and labeling of the product; | ||||||
| 12 | (3) The manner of distribution, advertising, and | ||||||
| 13 | promotion of the product; | ||||||
| 14 | (4) Verbal representations made concerning the | ||||||
| 15 | product; | ||||||
| 16 | (5) The duration, scope, and significance of misuse of | ||||||
| 17 | the particular product. | ||||||
| 18 | (c) A violation of this Section is a Class A misdemeanor. A | ||||||
| 19 | second or subsequent violation of this Section is a Class 4 | ||||||
| 20 | felony. | ||||||
| 21 | (d) This Section does not apply to dietary supplements, | ||||||
| 22 | herbs, or other natural products, including concentrates or | ||||||
| 23 | extracts, which: | ||||||
| 24 | (1) are not otherwise prohibited by law; and | ||||||
| 25 | (2) may contain naturally occurring ephedrine, | ||||||
| 26 | ephedrine alkaloids, or pseudoephedrine, or their salts, | ||||||
| |||||||
| |||||||
| 1 | isomers, or salts of isomers, or a combination of these | ||||||
| 2 | substances, that: | ||||||
| 3 | (i) are contained in a matrix of organic material; | ||||||
| 4 | and | ||||||
| 5 | (ii) do not exceed 15% of the total weight of the | ||||||
| 6 | natural product. | ||||||
| 7 | (e) Nothing in this Section limits the scope or terms of | ||||||
| 8 | the Methamphetamine Precursor Control Act. | ||||||
| 9 | (f) This Section does not apply to the sale of any product | ||||||
| 10 | dispensed or delivered by a practitioner or pharmacy according | ||||||
| 11 | to a prescription issued by a prescriber authorized by this | ||||||
| 12 | State or another state for a valid medical purpose and in the | ||||||
| 13 | course of professional practice. | ||||||
| 14 | (Source: P.A. 103-881, eff. 1-1-25.) | ||||||